Search - tctmd.com

Displaying 1 - 20 of 264

Sort: Relevancy | Date

INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen Over Time

News Conference News TCT 2025

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

Michael O'Riordan

October 29, 2025

News Conference News ESC 2024

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Michael O'Riordan

September 09, 2024

News Conference News EuroPCR 2024

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

Michael O'Riordan

May 28, 2024

Presentation TCT 2023

TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

Presenter: Imran Shah

October 25, 2023

News Conference News EuroPCR 2023

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

Michael O'Riordan

May 18, 2023

News Conference News EuroPCR 2023

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

Caitlin E. Cox

May 17, 2023

News Conference News TCT 2022

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

Yael L. Maxwell

September 27, 2022

Presentation TCT 2022

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

Presenter: ShaoLiang Chen

September 17, 2022

Presentation EuroPCR 2022

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Presenter: Giuseppe Tarantini

May 31, 2022

News Conference News EuroPCR 2022

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Caitlin E. Cox

May 25, 2022

News Conference News EuroPCR 2022

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

Michael O'Riordan

May 18, 2022

News Conference News

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

Caitlin E. Cox

March 02, 2022

News Conference News TCT 2021

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

Yael L. Maxwell

November 04, 2021

News Conference News TCT 2021

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Michael O'Riordan

November 04, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Daily News

FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk

Michael O'Riordan

June 30, 2021

News Conference News EuroPCR 2021

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

L.A. McKeown

May 19, 2021

News Conference News CRT 2021

Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8

Yael L. Maxwell

March 18, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

Advertisement

INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES Over Time

‘Unlocking’ Scaffold Matches DES in Wide Range of PCI Patients, Including ACS

Solid 2-Year Data With ‘Unlocking’ Coronary Stent: BIOADAPTOR RCT

TCT 606: Alterations in the Endothelial Wall Shear Stress Due to the Presence of the Stent Footprint: Comparison Between Xience and Resolute Stent Platforms

‘Fascinating’ Unlocking Coronary Stent Prompts Cautious Praise

For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients

5-Year RESTORE SVD China Trial: Restore DCB vs. DES Resolute Integrity in SVD

The ROLEX Study(Revascularization Of LEft main with resolute onyX): A prospective, international, multicenter study of left main PCI with a zotarolimus-eluting stent

Imaging in PCI for Patients at High Bleeding Risk: Data Point to Possibilities

Intravascular Imaging Boosts Outcomes in Left Main PCI: ROLEX

BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years

‘Sweet Like SUGAR’: Polymer-Free Stent Noninferior to ZES in Diabetic Patients

FAME 3: PCI Fails to Demonstrate Noninferiority to Surgery in Three-Vessel CAD

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

FDA Permits 28-Day DAPT in Xience-Treated Patients at High Bleeding Risk

The Skinny on Ultrathin DES: Meta-analysis Shows Some Long-term Advantages

Polymer-Free Stent Noninferior to ZES at 3 Years: ReCre8

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content